Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Orexigen Therapeutic (OREX)

Orexigen Therapeutic (OREX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,212
  • Shares Outstanding, K 18,890
  • Annual Sales, $ 33,710 K
  • Annual Income, $ -24,520 K
  • 60-Month Beta 2.46
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.51
  • Most Recent Earnings -1.35 on 11/13/17
  • Next Earnings Date 05/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.67
  • Growth Rate Est. (year over year) +21,491.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.17 +31.18%
on 03/27/18
1.42 -84.30%
on 03/09/18
-0.99 (-81.57%)
since 03/02/18
3-Month
0.17 +31.18%
on 03/27/18
1.60 -86.06%
on 02/22/18
-1.02 (-82.02%)
since 01/03/18
52-Week
0.17 +31.18%
on 03/27/18
3.81 -94.15%
on 04/27/17
-2.61 (-92.12%)
since 04/03/17

Most Recent Stories

More News
BRG Wins Healthcare/Life Sciences Deal of the Year at M&A Advisor Turnaround Awards

The M&A Advisor announced BRG as winner of the Healthcare/Life Sciences Deal of the Year (Under $500 million) in its 13th Annual Turnaround Awards. BRG Managing Directors Haywood Miller and Peter Chadwick...

OREX : 0.22 (-34.41%)
Trade OREX with:

Business Summary

OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III...

See More

Key Turning Points

2nd Resistance Point 0.35
1st Resistance Point 0.29
Last Price 0.22
1st Support Level 0.19
2nd Support Level 0.15

See More

52-Week High 3.81
Fibonacci 61.8% 2.42
Fibonacci 50% 1.99
Fibonacci 38.2% 1.56
Last Price 0.22
52-Week Low 0.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar